Real‐World Comparative Effectiveness and Safety of Non‐Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in a Developing Country
P Mitsuntisuk, S Nathisuwan… - Clinical …, 2021 - Wiley Online Library
We aimed to compare effectiveness and safety of the non‐vitamin K antagonist oral
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
anticoagulants (NOACs) vs. warfarin for stroke prevention in nonvalvular atrial fibrillation …
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational …
M Durand, ME Schnitzer, M Pang, G Carney… - … Open Access Journal, 2020 - cmajopen.ca
Background: Direct oral anticoagulants (DOACs) have widely replaced warfarin for stroke
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
prevention in nonvalvular atrial fibrillation. Our objective was to compare the safety and …
The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared …
Background Although randomized trials provide a high level of evidence regarding the
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
efficacy of non-vitamin K oral anticoagulants (NOACs), the results of such trials may differ …
Outcomes after use of standard-and low-dose non–vitamin k oral anticoagulants in Asian patients with atrial fibrillation
MS Cho, JE Yun, JJ Park, YJ Kim, J Lee, H Kim… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Limited data are available describing the relative effectiveness,
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
safety, and optimal dosing of non–vitamin K antagonist oral anticoagulants (NOACs) for …
Effectiveness and safety of contemporary oral anticoagulants among Asians with nonvalvular atrial fibrillation
Background and Purpose—Limited evidence exists on the effectiveness and safety of
warfarin and all 4 available non-vitamin K antagonist oral anticoagulants (NOACs) from …
warfarin and all 4 available non-vitamin K antagonist oral anticoagulants (NOACs) from …
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
GYH Lip, A Keshishian, S Kamble… - Thrombosis and …, 2016 - thieme-connect.com
In addition to warfarin, there are four non-vitamin K antagonist oral anticoagulants (NOACs)
available for stroke prevention in non valvular atrial fibrillation (NVAF). There are limited …
available for stroke prevention in non valvular atrial fibrillation (NVAF). There are limited …
Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular …
CI Coleman, JB Briere, L Fauchier, P Levy… - Journal of market …, 2019 - mdpi.com
Introduction: Numerous real-world studies have compared non-vitamin K antagonist oral
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
anticoagulants (NOACs) with vitamin K antagonists (VKAs) in patients with non-valvular …
Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular …
Background The global real-life impact of non-vitamin K antagonist oral anticoagulants
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
(NOACs) introduction in the healthcare system in a setting of well-managed vitamin K …
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation
Background and Purpose—There are limited real-world data comparing the effectiveness
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …
and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in Asians …
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
V Sjögren, B Byström, H Renlund, PJ Svensson… - PloS one, 2017 - journals.plos.org
Background For patients with atrial fibrillation, non-vitamin K oral anticoagulants, or NOACs
(dabigatran, rivaroxaban, edoxaban, and apixaban) have been proven non-inferior or …
(dabigatran, rivaroxaban, edoxaban, and apixaban) have been proven non-inferior or …